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ABSTRACT
Objectives The aim of our study was to assess whether there is a relationship between maternal body mass index
(BMI) and umbilical artery Doppler velocimetry in physiologic pregnancies.
Methods Healthy pregnancy women, referred to our center at or before 32weeks of gestation, were recruited.
According to BMI, they were divided into underweight (BMI< 18.5), normal weight (BMI 18.5–24.9), overweight (BMI
25.0–29.9) and obese women (BMI ≥ 30). At 32+0weeks of gestation, maternal BMI and umbilical artery Doppler
velocimetry were recorded. A correlation between pulsatility index of umbilical artery and BMI was assessed by
one-way ANOVA test, multiple comparison test (Bonferroni correction) and polynomial regression.
Results One hundred eighty-ﬁve women were included. Mean pulsatility index of umbilical artery at 32+0 was
signiﬁcantly higher in obese women (0.95 ± 0.01 vs 0.87 ± 0.01 vs 0.67 ± 0.01; p< 0.05). We found a positive correlation
between Pulsatility Index of Umbilical Artery and maternal BMI (r2 = 0.7; p< 0.05).
Conclusion There is a positive correlation between BMI and pulsatility index of umbilical artery. These ﬁndings
suggest that obesity has a negative effect on feto-placetal vessels. If our data will be conﬁrmed, maternal BMI should
be considered in evaluation of umbilical Doppler velocimetry. © 2014 John Wiley & Sons, Ltd.
Funding sources: None
Conﬂicts of interest: None declared
INTRODUCTION
Bodymass index (BMI) is a simple index of weight for height that
is commonly used to classify overweight and obesity in adults. It
is deﬁned as a person’s weight in kilograms divided by the square
of his height in meters (kg/m2). According to the Institute of
Medicine, people are classiﬁed into four groups: underweight
(BMI< 18.5), normal weight (BMI 18.5–24.9), overweight (BMI
25.0–29.9) and obese (BMI≥ 30).1
Nowadays, obesity is one of the most important public
health problem. According to a WHO report, in 2008, more
than 1.4 billion adults, 20 and older, were overweight. Of
these, over 200 million men and nearly 300 million women
were obese.2 We expect that obese people will be more than
700 million in 2015.3 In Italy, the prevalence of overweight
(from 33.9% in 2001 to 36.1% in 2009) and obesity (from 8.5
in 2001 to 10.3% in 2009) has been progressively increasing
in the last decade. Overweight and obesity are more
common in Southern Italy, and our region has the highest
prevalence (51.8%).4
Several studies have shown that obesity increases the risk
of pregnancy complication such as gestational diabetes,
preeclampsia, infections, post-term pregnancy and cesarean
section delivery.5–8 However, it remains unclear whether obesity
by itself, independent of diabetes and hypertension, is a
predictor of adverse pregnancy outcome.
Furthermore, scanning obese pregnant women is very
difﬁcult, and visualization rates of fetal anatomy fell by 14.5%
if the BMI was >90th centile.9
To the best of our know1edge, there are no previous studies
discussing the inﬂuence of BMI on umbilical artery (UA)
Doppler velocimetry.
The aim of our study was to evaluate a possible relationship
between BMI and UA pulsatility index (UA-PI) in physiologic
pregnancies.
METHODS
This was a prospective cohort study conducted in a single
tertiary referral center over a two-year period from 2012
to 2014. Only uncomplicated pregnancies were included in
our study. Inclusion criteria were as follows: singleton
pregnancy, gestational age ≤ 32weeks, absence of fetal structural
abnormalities, absence of maternal comorbidities and/or
complications and no drugs intake. Pregnancies complicated
by fetal abnormality, aneuploidy, antepartum stillbirth, or
maternal complications were excluded from analysis. Given the
association between smoking and UA Doppler measures,10
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smokers were excluded as well. Written informed consent was
obtained from the women recruited in the study. Gestational
age was deﬁned according to the crown–rump length at the ﬁrst
ultrasound scan.
All the women recruited underwent a feto-maternal
assessment at 32+0weeks of gestation. Maternal weight and
height were measured, and BMI was calculated and recorded
on a dedicated database. Women were divided into four
groups, according to Institute of Medicine recommendations.1
Demographic, clinical and anamnestic data were regularly
recorded. At the same appointment, a fetal ultrasound
examination was performed. The UA was examined using color
Doppler, and the PI was measured according to a standard
protocol11 and recorded. In brief, UA-PI values were obtained
in free loops of the umbilical cord, and the UA-PI was
calculated by the automatic trace. Ultrasound examinations
were performed with a Voluson E8 (GE Medical Systems, Zipf,
Austria) ultrasound machine equipped with a 3.5-MHz convex
probe, during fetal quiescence, in the absence of fetal
tachycardia, and keeping the insonation angle with the
examined vessels as small as possible. After delivery, maternal
and neonatal outcome was collected.
Statistical analysis was performed using Statistical Package
for Social Sciences (SPSS) v. 19.0 (IBM Inc., Armonk, NY,
USA). Data were shown as means ± error standards (ES) or
number (percentage). Differences in UA-PI among groups
were assessed by one-way ANOVA test and Bonferroni
correction. A polynomial regression was performed to analyze
the relationship between UA-PI and maternal BMI. p-value
<0.05 was considered statistically signiﬁcant.
RESULTS
One hundred eighty-ﬁve singleton physiologic pregnancies
were included in our study. At 32+0weeks of gestation, 3
(1.6%) women were underweight, 99 (53.5%) normal weight,
43 (23.2%) overweight and 40 (21.6%) obese. Considering that
the number of underweight pregnant women was extremely
low in our cohort, we decided to exclude them from our
analysis. Maternal age (28.2 ± 4.9 vs 28.6 ± 5.3 vs 28.5 ± 6.2;
p = 0.89) and rate of nulliparity (50 (48.5) vs 16 (37.2) vs 17
(42.5); p = 0.43) were similar in normal weight, overweight and
obese women. All the recruited women were Caucasian.
Mean UA-PI at 32+0weeks of gestation was signiﬁcantly
higher in obese women (0.95 ± 0.01 vs 0.87 ± 0.01 vs 0.67
± 0.01; p< 0.05, one-way ANOVA test) even after multiple
comparison by Bonferroni correction (p< 0.05). We found a
positive correlation between UA-PI and maternal BMI
(r 2 = 0.7; p< 0.05; Figure 1). Neonatal outcome was not
signiﬁcantly different among groups as shown in Table 1. No
neonatal complications were reported.
DISCUSSION
Nowadays, obesity is becoming a very important healthy issue.
The percentage of obese adults is constantly rising.2
The main ﬁnding from our cohort was the presence of a
positive correlation between maternal BMI and UA-PI.
According to these results, in uncomplicated pregnancies, the
bigger is the maternal BMI, the higher the resistance in UA.
An additional ﬁnding in our cohort was the absence of
signiﬁcant differences in the fetal birth weight and other fetal
outcome measures among the three BMI groups.
We used a sample composed of physiologic pregnant women
who delivered at term to avoid the inﬂuences of potentially
confounding factors, such as preeclampsia or diabetes.12
The ﬁndings from the present study suggest that the
mechanism underlying the higher prevalence of pregnancy
complications among obese women is mediated by placental
insufﬁciency.
Obesity seems to have a negative inﬂuence on feto-placental
vessels; therefore, a woman with a higher BMI needs higher
resistances in fetal UA to deliver a wellbeing fetus, compared
with the ones with a normal or lower BMI. Indeed, it has been
previously reported that obesity is related with adverse
feto-maternal outcome.13
Association between obesity and adverse pregnancy
outcome is well established from previous studies,14,15 and
increase in the risk of pregnancy complication such as
gestational diabetes, preeclampsia, infections, post-term
pregnancy and caesarean section delivery has been previously
demonstrated.5–8 Obesity has also been investigated as an
independent risk factor for adverse fetal outcome. The
association between obesity and adverse fetal outcome has
been reported in large cohort studies, and obesity has been
Figure 1 Correlation between UA-PI and maternal BMI (r2 = 0.7;
p< 0.05)










38.6 ± 0.2 38.5 ± 0.2 38.1 ± 0.2
Birth weight 3341 ± 37.1 3449 ± 67.9 3427 ± 55.4
5 min Apgar 9.2 ± 0.1 9.2 ± 0.1 9.3 ± 0.1
5 min Apgar ≤ 7 — — °
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proven to increase the risk of late fetal death in nulliparous
women, even in the absence of any hypertensive disease.15
However, Chalouhi et al. demonstrated that obese women
who are glucose-tolerant and non-hypertensive may not be at
increased risk of perinatal mortality, but they analyzed only
the neonatal UA blood gas parameters, without considering
UA Doppler velocimetry.16
Moreover, it has been previously reported that apparently
healthy obese women have a lower microvascular reactivity.17
Inappropriate secretion of several adipokines by the excessive
amount of white adipose tissue seems to participate in the
pathogenesis of obesity-related pathologic processes including
endothelial dysfunction and inﬂammation.18 This process
could also inﬂuence uterine and placental perfusion.
A proinﬂammatory maternal and fetal environment has
been proposed to be involved in mediating adverse maternal
and fetal outcomes in obese pregnant women.19 Adiponectin
plays a vasoprotective role in the systemic circulation by
preventing vascular smooth muscle proliferation, thus main-
taining vessel caliber. Leptin is implicated in atherosis, in the
genesis of vascular calciﬁcation and vascular smooth muscle
proliferation, thus limiting caliber and distensibility of vessels.
An imbalance among those mechanisms may effect placental
circulation in maternal obesity. A higher prevalence of vas-
cular lesions in the placenta of obese women has also been
recently demonstrated.20 Maternal obesity has been shown to
be associated with a higher risk of vascular lesions of maternal
and fetal origins and villous lesions of maternal and fetal
origins. Interestingly, the increase in the risk of vascular lesions
was consistent in obese women in a subsample of women
with no hypertensive diseases and diabetes,20 conﬁrming the
value of obesity as an independent risk factor for placental
vascular damage.
Our ﬁndings support this speculation. Indeed, a higher
UA-PI in the group of women with higher BMI might reﬂect
the presence among this group of a higher prevalence of
placental insufﬁciency.
Obesewomen are expected to give birth to bigger neonates.21,22
The absence of a signiﬁcant difference in the birth weight
among the three groups, namely the absence of higher birth
weights in the neonates of obese mothers, may suggest a
higher prevalence of occult growth restriction in that group.
Hence, fetuses of obese mothers may have achieved a weight
within the population standards (thus appearing normal
in weight), despite failing to reach their potential of growth
(thus appearing smaller than they should), as an effect of
placental hypoxemia. Recent studies suggest that a fetus does
not have to be small to be growth restricted and that fetal
Doppler indices may be a better marker than the fetal size for
placental insufﬁciency, fetal hypoxemia and failing to reach the
potential of growth.23 Our ﬁnding of increasing resistance in
the UA in well-grown fetuses of obese mothers may furthermore
suggest that a higher proportion of these fetuses are suffering
placental insufﬁciency.
To the best of our knowledge, this is the ﬁrst published study
about this issue.
The main limitation of our study is the limited sample size,
even if the strong correlation found is quite cheering.
Further studies with enlarged samples should be performed to
conﬁrm our data. Moreover, it should be important to conﬁrm
the reported relationship at every gestational age and to extend
this analysis to the other feto-placental vessels and to pathologic
fetuses. If our data will be conﬁrmed, maternal BMI should be
considered in evaluation of UA Doppler velocimetry.
WHAT’S ALREADY KNOWN ABOUT THIS TOPIC?
• Obesity increases the risk of pregnancy complications and maternal
and neonatal outcome.
• Obesity can inﬂuence vascular reactivity and endothelial functions.
WHAT DOES THIS STUDY ADD?
• This is the ﬁrst study assessing the relationship between maternal
BMI and umbilical artery Doppler velocimetry.
• We found a positive correlation between maternal BMI and
pulsatility index of umbilical artery. According to these results, in
uncomplicated pregnancies, the bigger is the maternal BMI, the
higher the resistance in umbilical artery.
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